Tecvayli (teclistamab)

teclistamab · Genmab and Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tecvayli (teclistamab), covering 2026-04-13 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma [Phase 2]